FDA Approves a New Obesity Drug Poised to Dethrone Wegovy ...Middle East

There’s officially a new and fierce competitor for Novo Nordisk’s Wegovy (semaglutide) when it comes to weight loss. On Wednesday, the Food and Drug Administration approved the drug tirzepatide, developed by Eli Lilly, as a treatment for obesity. The weekly injectable drug will be sold under the brand name Zepbound.Read more...

Hence then, the article about fda approves a new obesity drug poised to dethrone wegovy was published today ( Wednesday 08/11/2023 - 10:44 PM ) and is available on Gizmodo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA Approves a New Obesity Drug Poised to Dethrone Wegovy )

Also on site :

• Inside the epicenter of the Ebola outbreak in DRC as the virus spreads
• The Middle East war is testing the Gulf’s ambitions to become an AI hub
• Move over, seltzer. Non-carbonated drinks are taking the spotlight